Contraception in the COVID-19 pandemic: recommendations from the Korean society of contraception and reproductive health
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Coronavirus disease 2019 (COVID-19) is associated with a systemic inflammatory response that activates coagulation insymptomatic patients. In addition, a rare form of thrombosis has been reported in people who received the COVID-19vaccine, most of whom were women younger than 50 years of age. Considering that hormonal contraceptive methodswidely used by women of childbearing age increase the risk of thrombosis, the development of guidelines for theuse of hormonal contraceptives in the era of the COVID-19 pandemic is necessary. In this context, the Korean Societyof Contraception and Reproductive Health provides guidelines for issues regarding contraception and reproductivehealth during the pandemic.
Abstract
Coronavirus disease 2019 (COVID-19) is associated with a systemic inflammatory response that activates coagulation insymptomatic patients. In addition, a rare form of thrombosis has been reported in people who received the COVID-19vaccine, most of whom were women younger than 50 years of age. Considering that hormonal contraceptive methodswidely used by women of childbearing age increase the risk of thrombosis, the development of guidelines for theuse of hormonal contraceptives in the era of the COVID-19 pandemic is necessary. In this context, the Korean Societyof Contraception and Reproductive Health provides guidelines for issues regarding contraception and reproductivehealth during the pandemic.
참고문헌 (48)
- "Pulse survey on continuity of essential health services during the COVID-19 pandemic:interim report, 27 August 2020" (2020)[URL]
- Bietsch K, "Family planning during and after the West African Ebola crisis", Stud Fam Plann, 51, pp.71~86 (2020)
- Campbell AM, "An increasing risk of family violence during the COVID-19 pandemic : strengthening community collaborations to save lives", Forensic Science International : Reports, 2, pp.100089~ (2020)
- Cohen MA, "Special ambulatory gynecologic considerations in the era of coronavirus disease 2019(COVID-19)and implications for future practice", Am J Obstet Gynecol, 223, pp.372~378 (2020)
- HanffTC, "Thrombosis in COVID-19", Am J Hematol, 95, pp.1578~1589 (2020)
- Middeldorp S, "Incidence of venous thromboembolism in hospitalized patients with COVID-19", J Thromb Haemost, 18, pp.1995~2002 (2020)
- "Thrombosis with thrombocytopenia syndrome (TTS) following Janssen COVID-19 vaccine" (2021)[URL]
- "VAXZEVRIA/COVID-19 Vaccine AstraZeneca: link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia" (2021)[URL]
- "Patient management and clinical recommendations during the coronavirus (COVID-19) pandemic" (2020)[URL]
- "Coronavirus COVID-19: ESHRE statement on pregnancy and conception" (2021)[URL]
- Lambalk C, "Safety first-assisted human reproduction second", Human Reproduction, 35, pp.741~742 (2020)
- Stanley KE, "Coronavirus disease-19 and fertility : viral host entry protein expression in male and female reproductive tissues", Fertil Steril, 114, pp.33~43 (2020)
- Gonzalez DC, "A systematic review on the investigation of SARS-CoV-2 in Semen", Res Rep Urol, 12, pp.615~621 (2020)
- Kotlyar AM, "Vertical transmission of coronavirus disease 2019 : a systematic review and metaanalysis", Am J Obstet Gynecol, 224, pp.35~53 (2021)
- Veiga A, "Assisted reproduction and COVID-19 : a joint statement of ASRM, ESHRE, and IFFS", Fertil Steril, 114, pp.484~485 (2020)
- "Report of a WHO technical consultation on birth spacing" (2021)[URL]
- Makins A, "The negative impact of COVID-19 on contraception and sexual and reproductive health: could immediate postpartum LARCs be the solution?", Int J Gynaecol Obstet, 150, pp.141~143 (2020)
- Curtis KM, "U.S. medical eligibility criteria for contraceptive USE, 2016", MMWR Recomm Rep, 65, pp.1~103 (2016)
- "Ensuring access to family planning Services during COVID-19: a summary of CDC’s family planning recommendations for healthcare providers" (2020)[URL]
- van Hylckama Vlieg A, "The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type : results of the MEGA case-control study", BMJ, 339, pp.b2921~ (2009)
- Sidney S, "Recent combined hormonal contraceptives(CHCs)and the risk of thromboembolism and other cardiovascular events in new users", Contraception, 87, pp.93~100 (2013)
- Dinger J, "Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives", Contraception, 93, pp.378~385 (2016)
- Lidegaard Ø, "Thrombotic stroke and myocardial infarction with hormonal contraception", N Engl J Med, 366, pp.2257~2266 (2012)
- Lidegaard Ø, "Oral contraceptives and venous thromboembolism : a five-year national casecontrol study", Contraception, 65, pp.187~196 (2002)
- Dinger JC, "International active surveillance study of women taking oral contraceptives(INAS-OC Study)", BMC Med Res Methodol, 9, pp.77~ (2009)
- Heinemann LA, "Range of published estimates of venous thromboembolism incidence in young women", Contraception, 75, pp.328~336 (2007)
- Servante J, "Haemostatic and thromboembolic complications in pregnant women with COVID-19 : a systematic review and critical analysis", BMC Pregnancy Childbirth, 21, pp.108~ (2021)
- Rabinovich A, "DIC in obstetrics : diagnostic score, highlights in management, and international registry-communication from the DIC and Women's Health SSCs of the International Society of Thrombosis and Haemostasis", J Thromb Haemost, 17, pp.1562~1566 (2019)
- "FIGO committee on contraception and family planning statement on COVID‐19 and pregnancy" (2021)[URL]
- Klok FA, "Incidence of thrombotic complications in critically ill ICU patients with COVID-19", Thromb Res, 191, pp.145~147 (2020)
- Oxley TJ, "Large-vessel stroke as a presenting feature of COVID-19 in the young", N Engl J Med, 382, pp.e60~ (2020)
- Ramírez I, "Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic : recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de trombosis y hemostasia", Maturitas, 137, pp.57~62 (2020)
- Cagnacci A, "Reflections and recommendations on the COVID-19 pandemic : should hormone therapy be discontinued?", Maturitas, 138, pp.76~77 (2020)
- Seeland U, "Evidence for treatment with estradiol for women with SARS-CoV-2 infection", BMC Med, 18, pp.369~ (2020)
- Lee JH, "Effect of sex hormones on coronavirus disease 2019 : an analysis of 5, 061 laboratory-confirmed cases in South Korea", Menopause, 27, pp.1376~1381 (2020)
- Mauvais-Jarvis F, "Estradiol, progesterone, immunomodulation, and COVID-19 outcomes", Endocrinology, 161, pp.bqaa127~ (2020)
- Stelzig KE, "Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells", Am J Physiol Lung Cell Mol Physiol, 318, pp.L1280~L1281 (2020)
- Lippi G, "D-dimer is associated with severity of coronavirus disease 2019 : a pooled analysis", Thromb Haemost, 120, pp.876~878 (2020)
- Tepper NK, "Progestin-only contraception and thromboembolism : a systematic review", Contraception, 94, pp.678~700 (2016)
- Lidegaard O, "Venous thrombosis in users of non-oral hormonal contraception : follow-up study, Denmark 2001-10", BMJ, 344, pp.e2990~ (2012)
- Greinacher A, "Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination", N Engl J Med, 384, pp.2092~2101 (2021)
- Muir KL, "Thrombotic thrombocytopenia after Ad26. COV2. S vaccination", N Engl J Med, 384, pp.1964~1965 (2021)
- Cushman M, "Epidemiology and risk factors for venous thrombosis", Semin Hematol, 44, pp.62~69 (2007)
- Bonnar J, "Coagulation effects of oral contraception", Am J Obstet Gynecol, 157(4 Pt 2), pp.1042~1048 (1987)
- Oldenburg J, "Diagnosis and management of vaccinerelated thrombosis following AstraZeneca COVID-19vaccination : guidance statement from the GTH", Hamostaseologie, 41, pp.184~189 (2021)
- "Vaccination in pregnant women" (2021)[URL]
- "COVID-19vaccines while pregnant or breastfeeding" (2021)[URL]
- "Update on WHO interim recommendations on COVID-19 vaccination of pregnant and lactating women" (2021)[URL]
